SLIDESHOW: Top 25 S.A.F.E. Dividend Stocks
By Dividend Channel Staff, updated Fri, April 19, 3:56 AM
This Slide: #3 of 25 |
#23. AbbVie Inc (NYSE:ABBV) — 3.77% Yield
AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and The Juvederm Collection of Fillers; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon and Synthroid.
View ABBV's Dividend History» ETFs holding ABBV
|
Open the Dividend Channel ABBV Page (in a new window) »
ABBV Next Dividend Date » (Projection based upon history) ABBV Dividend Growth Rate » Quotes delayed 20 minutes |
Buy (3.17 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: ABBV Forecast Based on data provided by Zacks Investment Research via Quandl.com |
|